Strs Ohio Immunovant, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Immunovant, Inc. stock. As of the latest transaction made, Strs Ohio holds 4,000 shares of IMVT stock, worth $110,040. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,000

Previous 17,500 77.14%

Holding current value

$110,040

Previous $462,000 76.19%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$27.51 - $27.51 $371,385 - $371,385	-13,500 Reduced 77.14%	4,000 $110,000
Q2 2024 Aug 05, 2024	BUY	$25.1 - $31.61 $45,180 - $56,898	1,800 Added 11.46%	17,500 $462,000
Q1 2024 May 13, 2024	SELL	$30.27 - $43.79 $75,675 - $109,475	-2,500 Reduced 13.74%	15,700 $507,000
Q4 2023 Jan 30, 2024	SELL	$31.31 - $44.19 $485,305 - $684,945	-15,500 Reduced 45.99%	18,200 $766,000
Q3 2023 Oct 26, 2023	SELL	$18.55 - $39.96 $44,520 - $95,904	-2,400 Reduced 6.65%	33,700 $1.29 Million
Q2 2023 Jul 31, 2023	SELL	$14.2 - $23.75 $24,140 - $40,375	-1,700 Reduced 4.5%	36,100 $684,000
Q1 2023 Aug 02, 2023	BUY	$15.27 - $19.72 $25,959 - $33,524	1,700 Added 4.71%	37,800 $586,000
Q1 2023 Apr 27, 2023	BUY	$15.27 - $19.72 $27,486 - $35,496	1,800 Added 5.0%	37,800 $586,000
Q4 2022 Jan 26, 2023	BUY	$6.59 - $17.75 $58,651 - $157,975	8,900 Added 32.84%	36,000 $639,000
Q4 2021 Jan 24, 2022	BUY	$7.33 - $9.32 $138,537 - $176,148	18,900 Added 230.49%	27,100 $230,000
Q3 2021 Oct 22, 2021	BUY	$7.01 - $11.37 $57,482 - $93,234	8,200 New	8,200 $71,000
Q1 2021 Apr 23, 2021	SELL	$13.08 - $49.6 $119,028 - $451,360	-9,100 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$36.36 - $52.71 $14,544 - $21,084	400 Added 4.6%	9,100 $420,000
Q3 2020 Dec 14, 2020	BUY	$22.61 - $38.9 $85,918 - $147,820	3,800 Added 77.55%	8,700 $306,000
Q2 2020 Jul 23, 2020	BUY	$13.87 - $28.44 $67,963 - $139,356	4,900 New	4,900 $119,000

Others Institutions Holding IMVT

# of Institutions

212

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account